Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Fentanyl versus remifentanil during laparoscopic gallbladder removal: effects on bowel recovery and pain

Official title: Effects of Intraoperative Fentanyl vs. Remifentanil on Postoperative Bowel Function and Pain Outcomes in Laparoscopic Cholecystectomy: A Randomized Controlled Trial

Run by Konya City Hospital · NCT07182097 · Data updated 2026-11-12

This compares fentanyl and remifentanil given during elective laparoscopic gallbladder removal to see which leads to faster bowel recovery and better pain control in adults 18–65.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment106 (estimated)
SponsorKonya City Hospital
Academic / other
Locations1 site (Karatay, Konya)
StatusRecruiting
StartedSeptember 19, 2025
Main results expectedApril 27, 2026
Study endsApril 30, 2026
Registry record updatedSeptember 23, 2025
Trial IDNCT07182097 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with ASA physical status I–II scheduled for elective laparoscopic cholecystectomy, who are opioid-naïve and have no major liver, renal, or gastrointestinal disease.

Probably not a fit

Patients with prior abdominal surgery, preexisting gastrointestinal disease, chronic opioid use, significant liver or kidney failure, emergency procedures, or surgeries expected to last over 90 minutes are excluded and unlikely to benefit from this comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, controlled comparison assigns adults undergoing elective laparoscopic cholecystectomy to receive either intraoperative fentanyl (bolus + infusion) or remifentanil (bolus + infusion) as their opioid component of anesthesia. The trial tracks postoperative bowel function (for example time to first flatus/bowel movement) and pain scores and analgesic needs in the early postoperative period. Investigators aim to balance remifentanil's rapid metabolism against its potential to cause opioid-induced hyperalgesia and higher postoperative opioid requirements, while considering fentanyl's tendency to accumulate with longer infusions. Single-center recruitment is at Konya City Hospital with standard inclusion and exclusion criteria to limit confounders like prior abdominal surgery or chronic opioid use.

Why it matters

Potential benefit: If successful, selecting the opioid that speeds bowel recovery and reduces pain could shorten hospital stays and lower postoperative opioid needs.

How similar studies have gone: Previous trials have compared remifentanil and fentanyl for pain and recovery with mixed results and limited, inconclusive data specifically addressing postoperative bowel recovery.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18-65 years
* American Society of Anesthesiologists (ASA) physical status I or II
* Scheduled for elective laparoscopic cholecystectomy
* Provided written informed consent

Exclusion Criteria:

* Opioid use preoperatively
* Previous abdominal surgery
* History of ileus or gastrointestinal disease
* Preoperative electrolyte imbalance
* Liver or renal failure
* Neuromuscular or psychiatric disorders
* Known allergy to study medications
* Emergency surgery
* Surgical duration exceeding 90 minutes

Where it's running

  • Konya City Hospital
    Karatay, Konya, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.